ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      BackApellis Pharmaceuticals Overview
      Apellis Pharmaceuticals Inc

      Apellis Pharmaceuticals Target Price

      Analysts' 12-month price predictions for APLS.

      Share Price

      $28.13

      Average Target Price

      $22.0021.8% downside

      1 analysts in the last 4 months

      High: $22 | Low: $22

      Analyst Recommendations

      No recommendations in the last 4 months.

      Revenue & Income Forecast

      Analysts' Target Prices

      DateAnalystPrice TargetCurrent Upside/Downside
      2025-07-30Scotiabank$2221.8% downsideOpen
      2024-11-06H.C. WainwrightDouglas Tsao$57102.6% upsideOpen
      2024-09-23Robert W. BairdColleen Kusy$92227.1% upsideOpen
      2024-09-20Stifel NicolausAnnabel Samimy$84198.6% upsideOpen
      2024-09-20Mizuho SecuritiesGraig Suvannavejh$3938.6% upsideOpen
      2024-09-16Mizuho SecuritiesGraig Suvannavejh$4249.3% upsideOpen
      2024-08-09Robert W. BairdColleen Kusy$96241.3% upsideOpen
      2024-08-08JefferiesAkash Tewari$82191.5% upsideOpen
      2024-08-02H.C. WainwrightDouglas Tsao$83195.1% upsideOpen
      2024-07-26Robert W. BairdColleen Kusy$86205.7% upsideOpen
      2024-07-01Mizuho SecuritiesGraig Suvannavejh$4974.2% upsideOpen
      2024-05-23Wells FargoDerek Archila$4870.6% upsideOpen
      2024-02-05JefferiesAkash Tewari$80184.4% upsideOpen
      2023-01-02Wells FargoDerek Archila$58106.2% upsideOpen
      2022-11-15J.P. Morgan$79180.8% upsideOpen
      2022-09-12Wedbush$67138.2% upsideOpen
      2022-09-08Stifel Nicolaus$65131.1% upsideOpen
      2022-08-18Oppenheimer$78177.3% upsideOpen
      2022-08-09Credit Suisse$5284.9% upsideOpen
      2022-08-09Goldman Sachs$102262.6% upsideOpen
      2022-08-09Raymond James$113301.7% upsideOpen
      2022-07-20Citigroup$86205.7% upsideOpen
      2022-06-23Stifel NicolausAnnabel Samimy$60113.3% upsideOpen
      2022-05-24Goldman Sachs$84198.6% upsideOpen
      2022-05-05Credit Suisse$4456.4% upsideOpen
      2022-05-05Raymond James$102262.6% upsideOpen
      2021-11-09BMO CapitalMatthew Luchini$69145.3% upsideOpen
      2021-11-09WedbushLaura Chico$280.5% downsideOpen
      2021-10-01JefferiesChris Howerton$74163.1% upsideOpen
      2021-10-01Cantor FitzgeraldAlethia Young$74163.1% upsideOpen
      2021-09-10Credit SuisseTiago Fauth$3835.1% upsideOpen
      2021-07-01Cowen & Co.Phil Nadeau$70148.8% upsideOpen
      HoMEÔçÒÒŮѸÀ×